Novanta Inc. (NOVT)
NASDAQ: NOVT · Real-Time Price · USD
115.94
-1.48 (-1.26%)
Dec 5, 2025, 4:00 PM EST - Market closed
Revenue Breakdown
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 26, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Automation Enabling Technologies Revenue | 497.95M | 490.62M |
Log In |
Log In |
Log In | Upgrade
|
| Medical Solutions Revenue (Post-Q3 2024 Reporting) | 462.36M | 458.63M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 960.31M | 949.25M |
Log In |
Log In |
Log In | Upgrade
|
Revenue Breakdown 2
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 26, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Precision Medicine and Manufacturing Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Medical Solutions Revenue (Pre-Q4 2024 Reporting) | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Robotics and Automation Revenue | 314.23M | 288.32M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 960.31M | 949.25M |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 26, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| United States Revenue | 504.50M | 487.11M |
Log In |
Log In |
Log In | Upgrade
|
| Germany Revenue | 107.42M | 123.24M |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Europe Revenue | 138.08M | 128.87M |
Log In |
Log In |
Log In | Upgrade
|
| China Revenue | 91.36M | 84.56M |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Asia-Pacific Revenue | 99.80M | 107.05M |
Log In |
Log In |
Log In | Upgrade
|
| Other Geographic Revenue | 19.16M | 18.40M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 960.31M | 949.25M |
Log In |
Log In |
Log In | Upgrade
|
Gross Profit
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 26, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Automation Enabling Technologies Gross Profit | 240.72M | 234.98M |
Log In |
Log In |
Log In | Upgrade
|
| Medical Solutions Gross Profit (Post-Q3 2024 Reporting) | 193.14M | 189.96M |
Log In |
Log In |
Log In | Upgrade
|
| Corporate and Shared Services Gross Profit | -3.62M | -3.39M |
Log In |
Log In |
Log In | Upgrade
|
| Gross Profit (Total) | 430.25M | 421.55M |
Log In |
Log In |
Log In | Upgrade
|
Gross Profit 2
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 26, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Precision Medicine and Manufacturing Gross Profit | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Medical Solutions Gross Profit (Pre-Q4 2024 Reporting) | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Robotics and Automation Gross Profit | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Corporate and Shared Services Gross Profit | -3.62M | -3.39M |
Log In |
Log In |
Log In | Upgrade
|
| Gross Profit (Total) | 430.25M | 421.55M |
Log In |
Log In |
Log In | Upgrade
|
EBIT
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 26, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Automation Enabling Technologies Operating Income | 116.60M | 106.40M |
Log In |
Log In |
Log In | Upgrade
|
| Medical Solutions Operating Income (Post-Q3 2024 Reporting) | 43.61M | 57.53M |
Log In |
Log In |
Log In | Upgrade
|
| Corporate and Shared Services Operating Income | -64.33M | -53.35M |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Other) | 1,000.00 | - |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Total) | 95.89M | 110.58M |
Log In |
Log In |
Log In | Upgrade
|
EBIT 2
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 26, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Precision Medicine and Manufacturing Operating Income | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Medical Solutions Operating Income (Pre-Q4 2024 Reporting) | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Robotics and Automation Operating Income | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Corporate and Shared Services Operating Income | -64.33M | -53.35M |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Total) | 95.89M | 110.58M |
Log In |
Log In |
Log In | Upgrade
|